 A STUDY TO COMPARE BMS-936558 TO THE PHYSICIANS CHOICE OF EITHER DACARBAZINE OR CARBOPLATIN AND PACLITAXEL IN ADVANCED MELANOMA PATIENTS THAT HAVE PROGRESSED FOLLOWING ANTI-CTLA-4 THERAPY CHECKMATE 037: 